203 related articles for article (PubMed ID: 25300235)
1. Re-evaluating the PCP challenge as a pre-clinical model of impaired cognitive flexibility in schizophrenia.
Fellini L; Kumar G; Gibbs S; Steckler T; Talpos J
Eur Neuropsychopharmacol; 2014 Nov; 24(11):1836-49. PubMed ID: 25300235
[TBL] [Abstract][Full Text] [Related]
2. Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat.
Abdul-Monim Z; Neill JC; Reynolds GP
J Psychopharmacol; 2007 Mar; 21(2):198-205. PubMed ID: 17329300
[TBL] [Abstract][Full Text] [Related]
3. Effects of risperidone, clozapine and the 5-HT6 antagonist GSK-742457 on PCP-induced deficits in reversal learning in the two-lever operant task in male Sprague Dawley rats.
de Bruin NM; van Drimmelen M; Kops M; van Elk J; Wetering MM; Schwienbacher I
Behav Brain Res; 2013 May; 244():15-28. PubMed ID: 23384714
[TBL] [Abstract][Full Text] [Related]
4. The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm.
Abdul-Monim Z; Reynolds GP; Neill JC
Behav Brain Res; 2006 May; 169(2):263-73. PubMed ID: 16500717
[TBL] [Abstract][Full Text] [Related]
5. Phencyclidine-induced cognitive impairments in repeated touchscreen visual reversal learning tests in rats.
Savolainen K; Ihalainen J; Hämäläinen E; Tanila H; Forsberg MM
Behav Brain Res; 2021 Apr; 404():113057. PubMed ID: 33316322
[TBL] [Abstract][Full Text] [Related]
6. A touch-screen based paired-associates learning (PAL) task for the rat may provide a translatable pharmacological model of human cognitive impairment.
Talpos JC; Aerts N; Fellini L; Steckler T
Pharmacol Biochem Behav; 2014 Jul; 122():97-106. PubMed ID: 24662914
[TBL] [Abstract][Full Text] [Related]
7. Activation of α7 nicotinic receptors improves phencyclidine-induced deficits in cognitive tasks in rats: implications for therapy of cognitive dysfunction in schizophrenia.
McLean SL; Grayson B; Idris NF; Lesage AS; Pemberton DJ; Mackie C; Neill JC
Eur Neuropsychopharmacol; 2011 Apr; 21(4):333-43. PubMed ID: 20630711
[TBL] [Abstract][Full Text] [Related]
8. The subchronic phencyclidine rat model: relevance for the assessment of novel therapeutics for cognitive impairment associated with schizophrenia.
Janhunen SK; Svärd H; Talpos J; Kumar G; Steckler T; Plath N; Lerdrup L; Ruby T; Haman M; Wyler R; Ballard TM
Psychopharmacology (Berl); 2015 Nov; 232(21-22):4059-83. PubMed ID: 26070547
[TBL] [Abstract][Full Text] [Related]
9. The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat.
Abdul-Monim Z; Reynolds GP; Neill JC
J Psychopharmacol; 2003 Mar; 17(1):57-65. PubMed ID: 12680740
[TBL] [Abstract][Full Text] [Related]
10. Strain-dependent effects on acquisition and reversal of visual and spatial tasks in a rat touchscreen battery of cognition.
Kumar G; Talpos J; Steckler T
Physiol Behav; 2015 May; 144():26-36. PubMed ID: 25744936
[TBL] [Abstract][Full Text] [Related]
11. NMDA and D2-like receptors modulate cognitive flexibility in a color discrimination reversal task in pigeons.
Herold C
Behav Neurosci; 2010 Jun; 124(3):381-90. PubMed ID: 20528082
[TBL] [Abstract][Full Text] [Related]
12. Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine.
Nabeshima T; Mouri A; Murai R; Noda Y
Ann N Y Acad Sci; 2006 Nov; 1086():160-8. PubMed ID: 17185514
[TBL] [Abstract][Full Text] [Related]
13. Temporally distinct cognitive effects following acute administration of ketamine and phencyclidine in the rat.
Gastambide F; Mitchell SN; Robbins TW; Tricklebank MD; Gilmour G
Eur Neuropsychopharmacol; 2013 Nov; 23(11):1414-22. PubMed ID: 23561394
[TBL] [Abstract][Full Text] [Related]
14. Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism.
Neill JC; Barnes S; Cook S; Grayson B; Idris NF; McLean SL; Snigdha S; Rajagopal L; Harte MK
Pharmacol Ther; 2010 Dec; 128(3):419-32. PubMed ID: 20705091
[TBL] [Abstract][Full Text] [Related]
15. PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats.
Rodefer JS; Murphy ER; Baxter MG
Eur J Neurosci; 2005 Feb; 21(4):1070-6. PubMed ID: 15787711
[TBL] [Abstract][Full Text] [Related]
16. Clozapine but not haloperidol treatment reverses sub-chronic phencyclidine-induced disruption of conditional discrimination performance.
Dunn MJ; Killcross S
Behav Brain Res; 2006 Dec; 175(2):271-7. PubMed ID: 17027093
[TBL] [Abstract][Full Text] [Related]
17. Evidence that aetiological risk factors for psychiatric disorders cause distinct patterns of cognitive deficits.
Wallace J; Marston HM; McQuade R; Gartside SE
Eur Neuropsychopharmacol; 2014 Jun; 24(6):879-89. PubMed ID: 24377755
[TBL] [Abstract][Full Text] [Related]
18. Comparing the effects of subchronic phencyclidine and medial prefrontal cortex dysfunction on cognitive tests relevant to schizophrenia.
McAllister KA; Mar AC; Theobald DE; Saksida LM; Bussey TJ
Psychopharmacology (Berl); 2015 Nov; 232(21-22):3883-97. PubMed ID: 26194915
[TBL] [Abstract][Full Text] [Related]
19. RP5063, an atypical antipsychotic drug with a unique pharmacologic profile, improves declarative memory and psychosis in mouse models of schizophrenia.
Rajagopal L; Kwon S; Huang M; Michael E; Bhat L; Cantillon M; Meltzer HY
Behav Brain Res; 2017 Aug; 332():180-199. PubMed ID: 28373127
[TBL] [Abstract][Full Text] [Related]
20. Spatial memory deficits induced by perinatal treatment of rats with PCP and reversal effect of D-serine.
Andersen JD; Pouzet B
Neuropsychopharmacology; 2004 Jun; 29(6):1080-90. PubMed ID: 14970828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
